Alan J Korman Selected Research

Stomach Neoplasms (Stomach Cancer)

7/2013

Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alan J Korman Research Topics

Disease

51	Neoplasms (Cancer) 10/2022 - 01/2006
15	Melanoma (Melanoma, Malignant) 01/2023 - 10/2007
5	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 07/2010
4	Infections 01/2018 - 01/2013
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 07/2010
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 07/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 07/2010
3	Glioma (Gliomas) 11/2020 - 01/2019
3	Multiple Myeloma 05/2017 - 07/2012
2	Inflammation (Inflammations) 01/2021 - 01/2016
2	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2020
2	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 11/2014
2	Body Weight (Weight, Body) 07/2013 - 06/2012
1	Ovarian Neoplasms (Ovarian Cancer) 11/2020
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Diarrhea 01/2018
1	Facial Paralysis (Facial Palsy) 01/2018
1	Viremia 01/2018
1	Carcinoma (Carcinomatosis) 09/2015
1	Stomach Neoplasms (Stomach Cancer) 07/2013
1	Colonic Neoplasms (Colon Cancer) 07/2013
1	Fungemia 05/2013
1	Mycoses (Diseases, Fungus) 05/2013
1	Sepsis (Septicemia) 05/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2013
1	Lymphoid Leukemia 01/2013
1	Disease Progression 01/2013
1	Chronic Hepatitis C 01/2013
1	Virus Diseases (Viral Diseases) 01/2013
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2012

Drug/Important Bio-Agent (IBA)

12	LigandsIBA 11/2019 - 04/2010
10	Monoclonal AntibodiesIBA 01/2021 - 01/2013
9	IpilimumabIBA 01/2022 - 07/2013
9	AntibodiesIBA 01/2021 - 04/2006
8	Immune Checkpoint InhibitorsIBA 10/2022 - 09/2015
7	NivolumabIBA 10/2022 - 01/2013
6	AntigensIBA 01/2021 - 04/2006
4	VaccinesIBA 01/2020 - 10/2007
3	Peptides (Polypeptides)IBA 01/2022 - 10/2007
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2015
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 05/2015
3	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 05/2017
3	ChemokinesIBA 01/2021 - 05/2017
3	urelumabIBA 01/2021 - 09/2015
3	Immunoconjugates (Immunoconjugate)IBA 11/2020 - 01/2019
3	CTLA-4 AntigenIBA 01/2019 - 07/2013
3	CytokinesIBA 01/2018 - 01/2016
3	Programmed Cell Death 1 ReceptorIBA 09/2015 - 07/2013
2	Dihydrotachysterol (AT 10)IBA 01/2023 - 07/2010
2	Interleukin-2 (IL2)IBA 01/2022 - 01/2018
2	Interferon-gamma (Interferon, gamma)IBA 11/2020 - 05/2013
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2019
2	Antinuclear AntibodiesIBA 01/2018 - 04/2010
2	Immunoglobulin G (IgG)IBA 01/2018 - 07/2013
2	Therapeutic UsesIBA 01/2018 - 08/2009
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 02/2015
2	Protein Subunit VaccinesIBA 12/2015 - 11/2014
2	EpitopesIBA 11/2014 - 01/2006
1	relatlimabIBA 10/2022
1	MucinsIBA 01/2022
1	InterferonsIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Chemokine ReceptorsIBA 01/2021
1	Interleukin-15 (Interleukin 15)IBA 10/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	malic acid (malate)IBA 01/2019
1	Dasatinib (BMS 354825)FDA Link 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Biopolymers (Biopolymer)IBA 01/2019
1	PolymersIBA 01/2019
1	Chemotactic FactorsIBA 10/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	OvalbuminIBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	Conditioned Culture MediaIBA 01/2018
1	HLA-DR Antigens (HLA-DR)IBA 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	elotuzumabIBA 05/2017
1	OligodeoxyribonucleotidesIBA 01/2017
1	MethylcholanthreneIBA 01/2017
1	interleukin-21 (interleukin 21)IBA 01/2017
1	Interleukin-12 (IL 12)IBA 11/2016
1	Interleukin-10 (Interleukin 10)IBA 02/2015
1	Indicators and Reagents (Reagents)IBA 02/2015
1	Mutant Proteins (Protein, Mutant)IBA 11/2014
1	ulocuplumabIBA 01/2013
1	Antiviral Agents (Antivirals)IBA 01/2013
1	Minor Histocompatibility AntigensIBA 07/2012

Therapy/Procedure

22	Therapeutics 01/2023 - 01/2006
22	Immunotherapy 01/2022 - 01/2006
3	Castration 01/2021 - 06/2012
2	Intravenous Infusions 01/2023 - 07/2010
1	Drug Therapy (Chemotherapy) 01/2022
1	Neoadjuvant Therapy 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 01/2021
1	Radiotherapy 10/2018
1	Punctures 05/2013
1	Ligation 05/2013